Construction of adeno-associated virus system for human bone morphogenetic protein 7 gene

Abstract

To construct the recombinant adeno-associated virus (rAAV) vector with human bone morphogenetic protein 7 (BMP7) and observe the BMP7 mRNA expression in vitro, BMP7 CDS sequence was cloned into expression plasmid pAAV-MCS of AAV Helper Free System. The recombinant plasmid was identified with enzyme digestion and sequencing. The recombinant plasmid, pAAV-RC, pHelper were co-transfected into AAV-293 cells according to the calcium phosphate-based protocol. The viral stock was collected by 4 rounds of freeze/thaw. After purified and concentrated, the recombinant virus titer was determined by dot-blot assay. HEK293 cells were transfected with the recombinant virus at different MOI, and the expression of BMP7 mRNA was detected by RT-PCR. The results showed rAAV-BMP7 was constructed and packaged successfully. The physical particle titer was 2.5×10¹¹ vector genomes/mL. There was different expression level of BMP7 mRNA after transfecton. These data suggested that recombinant AAV mediated a stable expression of hBMP7 mRNA in 293 cells. The AAV production method may pave the way of an effective strategy for the jaw bone defection around dental implants.

Keywords

human bone morphogenetic protein 7 / adeno-associated virus / jaw bone / gene therapy

References

[1] CookS. D., BaffesG. C., WolfeM. W., et al.. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop Relat Res, 1994, 301: 302-312

[2] WuX. B., DongX. Y., WuZ. J.. A quick and effective method to separate and purify recombinant adeno-associated virus 2. Chin Sci Bulletin (Chinese), 2000, 45(19): 2071-2075

[3] AuricchioA., HildingerM., O’ConnorE., et al.. Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum Gene Ther, 2001, 12: 71-76

[4] JamesE. F., CharlesN. C., GeorgeF. M.. Bone cells and matrices in orthopedic tissue engineering. Orthop Clin North Am, 2000, 31: 357-374

[5] SchliephakeH.. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg, 2002, 31(5): 469-484

[6] Ulrich-VintherM.. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing. Acta Orthop Suppl, 2007, 78(325): 1-64

[7] AthanasopoulosT., FabbS., DicksonG.. Gene therapy vectors based on adeno-associated virus: characteristics and applications to acquired and inherited diseases (review). Int J Mol Med, 2000, 6(4): 363-375

[8] ZhangM., LiF. P., ChenL. H., et al.. Construction of recombinant adiponectin adeno-associated virus vectors. Chin J Clin Rehab (Chinese), 2006, 10(20): 74-76

[9] KangJ. S., LiuZ. X., LanR. F., et al.. Effects of AAV-mediated CD151 gene on the neovascularization and foundation of blood flow in the model of rat hind-limb ischemia. J Huazhong Univ Sci Technol (Health Sciences) (Chinese), 2006, 35(5): 605-608

[10] ZhangJ. Y., ZhaoJ. X., ChenJ. F., et al.. Construction and identification of recombinant adeno-associated virus vector encoding BDNF by Helper-Free system. J Brain Nervous Dis (Chinese), 2007, 15(1): 25-29

[11] ZhengG. X., WeiJ. R., ZhuK., et al.. Construction of a general adeno-associated virus vector and GFP expression in rat NIH3T3 transduced by the rAAV vector. J Xi’an Jiaotong Univ (Medical Sciences) (Chinese), 2007, 28(1): 14-17

[12] Gallez-HawkinsG., LiX., FranckA. E., et al.. DNA and low titer, helper-free, recombinant AAV prime-boost vaccination for cytomegalovirus induces an immune response to CMV-pp65 and CMV-IE1 in transgenic HLA A*0201 mice. Vaccine, 2004, 23(6): 819-826

[13] ZolotukhinS., PotterM., ZolotukhinI., et al.. Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods, 2002, 28(2): 158-167

[14] StenderS., MurphyM., O’BrienT., et al.. Adeno-associated viral vector transduction of human mesenchymal stem cells. Eur Cell Mater, 2007, 31(13): 93-99

[15] KumarS., MahendraG., PonnazhaganS.. Determination of osteoprogenitor-specific promoter activity in mouse mesenchymal stem cells by recombinant adeno-associated virus transduction. Biochim Biophys Acta, 2005, 1731(2): 95-103

[16] WangR., CaoY. G., WangH. J., et al.. Construction of eukaryotic vector carrying TGF-β1 gene and its expression in bone mesenchymal stem cells. Chin J Histochem Cytochem (Chinese), 2005, 14(2): 217-220